Terms: = Colorectal cancer AND TCF7L2, ENSG00000148737, 6934, TCF-4 AND Prognosis
7 results:
1. Comprehensive genetic characterization of rectal cancer in a large cohort of Japanese patients: differences according to tumor location.
Hino H; Shiomi A; Hatakeyama K; Kagawa H; Manabe S; Yamaoka Y; Nagashima T; Ohshima K; Urakami K; Akiyama Y; Yamaguchi K
J Gastroenterol; 2022 Jul; 57(7):476-485. PubMed ID: 35449312
[TBL] [Abstract] [Full Text] [Related]
2. Characterization of genomic alterations in Chinese colorectal cancer patients.
Huang W; Li H; Shi X; Lin M; Liao C; Zhang S; Shi W; Zhang L; Zhang X; Gan J
Jpn J Clin Oncol; 2021 Jan; 51(1):120-129. PubMed ID: 33106877
[TBL] [Abstract] [Full Text] [Related]
3. Genomic profiling of microRNA target genes in colorectal cancer.
Fadaka AO; Bakare OO; Pretorius A; Klein A
Tumour Biol; 2020 Jun; 42(6):1010428320933512. PubMed ID: 32552466
[TBL] [Abstract] [Full Text] [Related]
4. TCF 4 tumor suppressor: a molecular target in the prognosis of sporadic colorectal cancer in humans.
Anwar M; Malhotra P; Kochhar R; Bhatia A; Mahmood A; Singh R; Mahmood S
Cell Mol Biol Lett; 2020; 25():24. PubMed ID: 32265994
[TBL] [Abstract] [Full Text] [Related]
5. colorectal cancer susceptibility loci and influence on survival.
Song N; Kim K; Shin A; Park JW; Chang HJ; Shi J; Cai Q; Kim DY; Zheng W; Oh JH
Genes Chromosomes Cancer; 2018 Dec; 57(12):630-637. PubMed ID: 30350386
[TBL] [Abstract] [Full Text] [Related]
6. Emergence of TNIK inhibitors in cancer therapeutics.
Yamada T; Masuda M
Cancer Sci; 2017 May; 108(5):818-823. PubMed ID: 28208209
[TBL] [Abstract] [Full Text] [Related]
7. OPG is regulated by beta-catenin and mediates resistance to TRAIL-induced apoptosis in colon cancer.
De Toni EN; Thieme SE; Herbst A; Behrens A; Stieber P; Jung A; Blum H; Göke B; Kolligs FT
Clin Cancer Res; 2008 Aug; 14(15):4713-8. PubMed ID: 18676739
[TBL] [Abstract] [Full Text] [Related]